10.3760/cma.j.cn321828-20230822-00030
神经内分泌肿瘤的肽受体放射性核素治疗:目前进展和未来方向
神经内分泌瘤、受体,肽、有机金属化合物、发展趋势
43
国家自然科学基金81960320,82272046;中央高水平医院临床科研专项项目2022-PUMCH-C-004,2022-PUMCH-D-002;中国医学科学院临床与转化医学研究专项2022-I2M-C&T-A-008;中国医学科学院医学与健康科技创新工程2022-I2M-2-002,2021-I2M-1-016;四川省自然科学基金2023NSFSC0635;四川省卫生健康委员会科技项目23LCYJ023;Natural National Science Foundation of China81960320, 82272046;National High Level Hospital Clinical Research Funding2022-PUMCH-C-004, 2022-PUMCH-D-002;Clinical and Translational Medicine Research Project of Chinese Academy of Medical Sciences2022-I2M-C&T-A-008;Chinese Academy of Medical Science Innovation Fund for Medical Sciences2022-I2M-2-002, 2021-I2M-1-016;Natural Science Foundation of Sichuan Province2023NSFSC0635;Science and Technology Project of Sichuan Provincial Health Commission23LCYJ023
2024-01-30(万方平台首次上网日期,不代表论文的发表时间)
共6页
695-700